AstraZeneca (AZN) stock news
Every headline mentioning AstraZeneca from Investing.com, Yahoo Finance and CNBC over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines0last 7 days · 3 in 30 days
Sentiment, 30 days
2 positive0 neutral1 negative
Latest headlineFri 11 Sep, 20:52 UTCHealthcare
Latest AZN headlines
Friday, 11 September 2026
Tuesday, 8 September 2026
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.